[HTML][HTML] Brigatinib combined with anti-EGFR antibody overcomes osimertinib resistance in EGFR-mutated non-small-cell lung cancer

K Uchibori, N Inase, M Araki, M Kamada, S Sato… - Nature …, 2017 - nature.com
Osimertinib has been demonstrated to overcome the epidermal growth factor receptor (EGFR)-T790M,
the most relevant acquired resistance to first-generation EGFR–tyrosine kinase …

Diagnosis and evaluation of hypersensitivity pneumonitis: CHEST guideline and expert panel report

…, CAC Pereira, MB Scholand, A Villar, N Inase… - Chest, 2021 - Elsevier
Background The purpose of this analysis is to provide evidence-based and consensus-derived
guidance for clinicians to improve individual diagnostic decision-making for …

The epidemiology of idiopathic pulmonary fibrosis and interstitial lung diseases at risk of a progressive-fibrosing phenotype

AL Olson, AH Gifford, N Inase… - European Respiratory …, 2018 - Eur Respiratory Soc
The availability of epidemiological data relating to interstitial lung diseases (ILDs) has increased
over recent years, but information on the prevalence and incidence of ILDs of different …

Long noncoding RNA HOTAIR is relevant to cellular proliferation, invasiveness, and clinical relapse in small‐cell lung cancer

…, S Okumura, M Nishio, T Hirose, N Inase… - Cancer …, 2014 - Wiley Online Library
Small‐cell lung cancer ( SCLC ) is a subtype of lung cancer with poor prognosis. To identify
accurate predictive biomarkers and effective therapeutic modalities, we focus on a long …

Clinical predictors and histologic appearance of acute exacerbations in chronic hypersensitivity pneumonitis

Y Miyazaki, T Tateishi, T Akashi, Y Ohtani, N Inase… - Chest, 2008 - Elsevier
Background Acute exacerbations (AEs) in idiopathic pulmonary fibrosis (IPF) are critical factors
for its clinical course and prognosis. We have seen AEs and poor prognosis consequent …

Inhalation provocation tests in chronic bird fancier's lung

Y Ohtani, K Kojima, Y Sumi, M Sawada, N Inase… - Chest, 2000 - Elsevier
Background Patients with chronic bird fancier's lung(BFL) can be classified into two types.
One group of patients developschronic disease with fluctuating acute episodes, including low-…

Clinical features of recurrent and insidious chronic bird fancier's lung

Y Ohtani, S Saiki, Y Sumi, N Inase, S Miyake… - Annals of Allergy …, 2003 - Elsevier
BACKGROUND: Chronic bird fancier's lung (BFL) can be subgrouped into two types. One
subgroup of patients develops interstitial pulmonary fibrosis after recurrent acute episodes (…

EBUS-TBNA as a promising method for the evaluation of tumor PD-L1 expression in lung cancer

…, Y Matsuura, M Nakao, M Mun, S Okumura, N Inase… - Clinical lung cancer, 2017 - Elsevier
Background Because most lung cancers are diagnosed at advanced stages, we are forced
to conduct molecular testing using small biopsy samples. Endobronchial ultrasound-…

GATA-1 regulates the generation and function of basophils

…, S Nakae, H Kanuka, N Inase… - Proceedings of the …, 2013 - National Acad Sciences
Developmental processes of hematopoietic cells are orchestrated by transcriptional
networks. GATA-1, the founding member of the GATA family of transcription factors, has been …

Pathology of hypersensitivity pneumonitis

T Takemura, T Akashi, Y Ohtani, N Inase… - Current opinion in …, 2008 - journals.lww.com
The present review focuses on the pathological features of chronic hypersensitivity pneumonitis
and presents that centrilobular fibrosis and bridging fibrosis are the important hallmarks …